173 related articles for article (PubMed ID: 33765507)
1. Analysis of intraoperative human brain tissue transcriptome reveals putative risk genes and altered molecular pathways in glioma-related seizures.
Feyissa AM; Carrano A; Wang X; Allen M; Ertekin-Taner N; Dickson DW; Jentoft ME; Rosenfeld SS; Tatum WO; Ritaccio AL; Guerrero-Cázares H; Quiñones-Hinojosa A
Epilepsy Res; 2021 Jul; 173():106618. PubMed ID: 33765507
[TBL] [Abstract][Full Text] [Related]
2. RNA Sequencing of Intraoperative Peritumoral Tissues Reveals Potential Pathways Involved in Glioma-Related Seizures.
Kumar K; Dubey V; Zaidi SS; Tripathi M; Siraj F; Sharma MC; Chandra PS; Doddamani R; Dixit AB; Banerjee J
J Mol Neurosci; 2023 Jun; 73(6):437-447. PubMed ID: 37268865
[TBL] [Abstract][Full Text] [Related]
3. Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis.
Jiang Y; He J; Guo Y; Tao H; Pu F; Li Y
J Cell Biochem; 2020 Jun; 121(5-6):3099-3111. PubMed ID: 31886582
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
5. Computational screening of potential glioma-related genes and drugs based on analysis of GEO dataset and text mining.
Jiang Z; Shi Y; Tan G; Wang Z
PLoS One; 2021; 16(2):e0247612. PubMed ID: 33635875
[TBL] [Abstract][Full Text] [Related]
6. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
7. Cysteine-rich 61-associated gene expression profile alterations in human glioma cells.
Wang R; Wei B; Wei J; Tian Y; Du C
Mol Med Rep; 2017 Oct; 16(4):5561-5567. PubMed ID: 28849002
[TBL] [Abstract][Full Text] [Related]
8. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.
Azevedo H; Fujita A; Bando SY; Iamashita P; Moreira-Filho CA
PLoS One; 2014; 9(11):e110934. PubMed ID: 25365520
[TBL] [Abstract][Full Text] [Related]
10. Identification of Differentially Expressed Genes and Signaling Pathways in Glioma by Integrated Bioinformatics Analysis.
Xu C; Su W; Jiang X
J Craniofac Surg; 2020; 31(8):2360-2363. PubMed ID: 33136891
[TBL] [Abstract][Full Text] [Related]
11. Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures.
Yao PS; Zheng SF; Wang F; Kang DZ; Lin YX
J Neurosurg; 2018 Mar; 128(3):840-845. PubMed ID: 28387627
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome analysis revealed CENPF associated with glioma prognosis.
Zhang M; Zhang Q; Bai J; Zhao Z; Zhang J
Math Biosci Eng; 2021 Mar; 18(3):2077-2096. PubMed ID: 33892537
[TBL] [Abstract][Full Text] [Related]
13. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic profiling of nonneoplastic cortical tissues reveals epileptogenic mechanisms in dysembryoplastic neuroepithelial tumors.
Kumar K; Banerjee Dixit A; Tripathi M; Dubey V; Siraj F; Sharma MC; Lalwani S; Chandra PS; Banerjee J
Funct Integr Genomics; 2022 Oct; 22(5):905-917. PubMed ID: 35633443
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
16. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated epilepsy and glioma: are there common genetic pathways?
Berntsson SG; Malmer B; Bondy ML; Qu M; Smits A
Acta Oncol; 2009; 48(7):955-63. PubMed ID: 19639468
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages based signaling pathway analysis and hub genes identification in glioma.
Wang X; Ning W; Qiu Z; Li S; Zhang H; Yu C
Medicine (Baltimore); 2020 Dec; 99(51):e23840. PubMed ID: 33371165
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.
Wang Y; Fan X; Zhang W; Zhang C; Wang J; Jiang T; Wang L
J Neurooncol; 2015 Feb; 121(3):609-16. PubMed ID: 25511798
[TBL] [Abstract][Full Text] [Related]
20. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
